Finance
Results: 433-444 of 43386

XBiotech Launches Phase II Clinical Trial Evaluating Vilamakitug for the Treatment of Active Axial Spondyloarthritis

World-first burn treatment with "absolutely remarkable" results performed at leading Canadian hospital


